# FDA Inspection 1078933 - CGG Medical Inc - February 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/cgg-medical-inc/8a722d79-204a-466e-b94d-13dc07e4071e
Source feed: FDA_Inspections

> FDA Inspection 1078933 for CGG Medical Inc on February 11, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078933
- Company Name: CGG Medical Inc
- Inspection Date: 2019-02-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269682 - 2025-04-24](https://www.keypedia.com/records/fda_inspections/cgg-medical-inc/f89f54f9-0ef7-4af6-9856-caf965c9c11f)
- [FDA Inspection 1269682 - 2025-04-24](https://www.keypedia.com/records/fda_inspections/cgg-medical-inc/b01f92d8-af18-4c69-ac6c-f038679de3f2)
- [FDA Inspection 1147263 - 2021-07-21](https://www.keypedia.com/records/fda_inspections/cgg-medical-inc/5ddc5e5f-d1a3-4abf-9584-3e5cb0e6d190)

Company: https://www.keypedia.com/companies/cgg-medical-inc/40a6e751-f818-455e-bd9c-7c1dd3017021

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d